NPI: 1588663769 · VISALIA, CA 93291 · Case Manager/Care Coordinator · NPI assigned 07/19/2005
Authorized official TUPPER, MALINDA controls 20+ related entities in our dataset. Read more
| Authorized Official | TUPPER, MALINDA (SRVP/CHIEF FINANCIAL OFFICER) |
| NPI Enumeration Date | 07/19/2005 |
Other providers sharing the same authorized official: TUPPER, MALINDA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 358,040 | $8.95M |
| 2019 | 345,492 | $8.37M |
| 2020 | 360,550 | $9.49M |
| 2021 | 445,771 | $11.92M |
| 2022 | 493,925 | $13.61M |
| 2023 | 559,223 | $17.11M |
| 2024 | 444,604 | $13.59M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 0450 | Emergency room services | 165,352 | 143,334 | $20.60M |
| 80053 | Comprehensive metabolic panel | 131,381 | 118,318 | $4.28M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 94,215 | 87,382 | $4.11M |
| 99199 | Unlisted special service, procedure or report | 58,929 | 48,307 | $3.00M |
| G9012 | Other specified case management service not elsewhere classified | 24,667 | 9,288 | $2.71M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 67,862 | 61,957 | $2.10M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 71,793 | 16,707 | $1.72M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 17,280 | 16,784 | $1.63M |
| 87428 | 33,482 | 31,779 | $1.45M | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 29,545 | 28,425 | $1.41M |
| 80048 | Basic metabolic panel (calcium, ionized) | 26,970 | 22,504 | $1.26M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 9,627 | 9,328 | $984K |
| 70450 | Computed tomography, head or brain; without contrast material | 14,459 | 14,019 | $895K |
| 0160 | 14,289 | 11,268 | $850K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 68,099 | 60,384 | $778K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 156,354 | 134,825 | $773K |
| 71046 | Radiologic examination, chest; 2 views | 48,351 | 45,907 | $767K |
| 97139 | 42,519 | 6,893 | $738K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 24,962 | 23,513 | $732K |
| H0043 | Supported housing, per diem | 5,355 | 1,657 | $649K |
| 97750 | 14,068 | 9,381 | $642K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 14,862 | 14,482 | $625K |
| 97010 | 13,987 | 3,898 | $594K | |
| 0760 | 18,017 | 15,379 | $593K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 47,881 | 43,442 | $559K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 17,939 | 15,757 | $558K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 724 | 695 | $509K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 3,889 | 3,863 | $501K |
| 95811 | 2,585 | 2,560 | $492K | |
| J3490 | Unclassified drugs | 12,646 | 10,555 | $468K |
| 84443 | Thyroid stimulating hormone (TSH) | 25,228 | 24,561 | $458K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 1,852 | 1,827 | $428K |
| 93325 | 4,403 | 4,365 | $423K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 31,117 | 29,201 | $415K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 5,533 | 5,485 | $407K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 899 | 879 | $405K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 1,409 | 1,396 | $381K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 13,440 | 12,369 | $377K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 13,820 | 13,186 | $366K |
| 0360 | 2,684 | 1,580 | $366K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 12,037 | 10,169 | $360K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 14,233 | 13,434 | $332K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 3,944 | 3,885 | $325K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 25,453 | 24,537 | $324K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 3,861 | 3,767 | $312K |
| 99215 | Prolong outpt/office vis | 5,887 | 5,697 | $308K |
| 72125 | Computed tomography, cervical spine; without contrast material | 4,662 | 4,579 | $302K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 18,139 | 16,054 | $300K |
| 80061 | Lipid panel | 22,642 | 22,324 | $298K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 8,596 | 8,334 | $297K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 11,137 | 10,848 | $294K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 1,634 | 1,583 | $290K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 6,397 | 6,223 | $288K |
| 84484 | 43,849 | 37,592 | $287K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 16,045 | 14,775 | $287K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 11,132 | 10,849 | $282K |
| 87634 | 7,868 | 7,592 | $265K | |
| 71045 | Radiologic examination, chest; single view | 22,481 | 21,395 | $263K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 26,621 | 25,820 | $254K |
| 83036 | Hemoglobin; glycosylated (A1C) | 22,247 | 21,885 | $254K |
| J2785 | Injection, regadenoson, 0.1 mg | 1,928 | 1,832 | $254K |
| 96361 | Intravenous infusion, hydration; each additional hour | 18,791 | 16,677 | $252K |
| 36415 | Collection of venous blood by venipuncture | 68,083 | 56,088 | $244K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 11,993 | 11,854 | $241K |
| 93320 | 3,878 | 3,852 | $235K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 5,936 | 3,961 | $217K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 1,138 | 1,127 | $208K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 6,244 | 6,065 | $195K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2,502 | 2,315 | $195K |
| 81001 | 63,194 | 59,041 | $194K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 13,431 | 12,089 | $193K |
| 82803 | 20,903 | 19,212 | $193K | |
| Z7502 | 5,069 | 4,970 | $192K | |
| 0270 | 3,802 | 3,406 | $189K | |
| 76770 | 4,135 | 3,998 | $183K | |
| 76801 | 6,322 | 5,531 | $183K | |
| J1815 | Injection, insulin, per 5 units | 2,765 | 1,790 | $172K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 2,812 | 2,739 | $172K |
| 0720 | 3,527 | 2,587 | $167K | |
| 76830 | Ultrasound, transvaginal | 4,858 | 4,762 | $166K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 5,407 | 5,311 | $166K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 2,184 | 2,058 | $164K |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 1,510 | 1,483 | $163K |
| 70496 | 1,680 | 1,651 | $160K | |
| 82330 | 19,817 | 18,326 | $159K | |
| 87481 | 5,233 | 4,905 | $158K | |
| G9008 | Coordinated care fee, physician coordinated care oversight services | 1,343 | 965 | $157K |
| 81025 | 18,338 | 17,208 | $155K | |
| 97799 | 9,621 | 1,697 | $154K | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 1,964 | 1,913 | $151K |
| 83605 | 24,948 | 22,407 | $150K | |
| 73130 | 6,981 | 6,672 | $148K | |
| 93971 | 3,171 | 3,064 | $147K | |
| 83880 | 11,733 | 10,953 | $145K | |
| 0761 | 4,081 | 3,412 | $141K | |
| 97165 | 3,485 | 2,938 | $140K | |
| 73630 | 6,640 | 6,411 | $137K | |
| 73610 | 5,883 | 5,699 | $136K | |
| 83690 | 38,030 | 35,141 | $133K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 10,099 | 9,248 | $133K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 814 | 813 | $131K |
| 93970 | 1,404 | 1,374 | $130K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2,513 | 2,479 | $129K |
| 83735 | 25,475 | 20,666 | $129K | |
| 76641 | 2,393 | 2,329 | $128K | |
| 93017 | 3,530 | 3,394 | $123K | |
| 80074 | 2,788 | 2,762 | $123K | |
| 73030 | 5,652 | 5,355 | $122K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 25,425 | 24,196 | $120K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 10,008 | 8,652 | $120K |
| 80076 | 5,077 | 4,706 | $118K | |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 1,748 | 1,516 | $117K |
| 72141 | 556 | 552 | $115K | |
| 70498 | 1,985 | 1,947 | $114K | |
| 82947 | 31,918 | 25,780 | $113K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,785 | 1,762 | $107K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 5,517 | 5,480 | $106K |
| 72110 | 2,449 | 2,419 | $102K | |
| 86850 | 15,023 | 14,496 | $102K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 4,931 | 3,822 | $100K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 6,331 | 6,271 | $99K |
| 84439 | 13,089 | 12,762 | $94K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 1,169 | 1,111 | $93K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 3,897 | 1,642 | $92K |
| 82375 | 11,343 | 10,518 | $91K | |
| 86480 | 1,810 | 1,791 | $90K | |
| 70486 | 1,220 | 1,196 | $90K | |
| 96379 | 4,310 | 3,336 | $89K | |
| 59025 | Fetal non-stress test | 8,320 | 3,259 | $84K |
| 73110 | 4,438 | 4,266 | $83K | |
| G0378 | Hospital observation service, per hour | 1,246 | 1,093 | $83K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 8,712 | 2,896 | $82K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 31,647 | 29,185 | $82K |
| 99221 | 2,325 | 2,217 | $81K | |
| 73562 | 4,522 | 4,406 | $78K | |
| 93308 | 2,031 | 2,003 | $77K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 2,719 | 2,430 | $75K |
| 84702 | 11,902 | 10,504 | $75K | |
| 84703 | 24,081 | 22,814 | $74K | |
| 86803 | 3,619 | 3,586 | $73K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 496 | 408 | $71K |
| 73564 | 2,579 | 2,490 | $70K | |
| 0683 | 473 | 473 | $70K | |
| 82607 | 7,295 | 7,197 | $69K | |
| 73502 | 2,058 | 1,986 | $68K | |
| 90715 | 4,737 | 4,631 | $68K | |
| 74018 | 4,245 | 4,147 | $67K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 397 | 381 | $64K |
| 73080 | 2,742 | 2,669 | $61K | |
| 83789 | 4,710 | 4,525 | $60K | |
| 76819 | Fetal biophysical profile; without non-stress testing | 2,207 | 1,397 | $60K |
| 93458 | 107 | 100 | $58K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,668 | 1,588 | $58K |
| 87081 | 10,283 | 10,033 | $58K | |
| 85610 | 19,893 | 18,269 | $57K | |
| 83050 | 11,299 | 10,481 | $57K | |
| 72100 | 2,065 | 2,038 | $56K | |
| 87040 | 5,867 | 5,380 | $55K | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 436 | 433 | $55K |
| 73590 | 3,347 | 3,207 | $52K | |
| 84999 | 2,535 | 2,222 | $51K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 12,438 | 11,185 | $51K |
| 83721 | 14,816 | 14,630 | $51K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,660 | 2,500 | $49K |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 520 | 52 | $48K |
| 87430 | 2,823 | 2,774 | $47K | |
| 97803 | 1,494 | 1,200 | $47K | |
| 97161 | 1,474 | 1,138 | $46K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 10,672 | 9,668 | $46K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 175 | 163 | $45K |
| 76870 | 1,441 | 1,390 | $45K | |
| 94729 | 1,393 | 1,370 | $44K | |
| 86900 | 18,762 | 17,913 | $43K | |
| 86901 | 18,766 | 17,911 | $42K | |
| 73090 | 2,758 | 2,657 | $42K | |
| 94726 | 1,423 | 1,393 | $41K | |
| Q3014 | Telehealth originating site facility fee | 2,282 | 1,987 | $41K |
| 94060 | 1,562 | 1,535 | $41K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 8,824 | 8,415 | $40K |
| 77066 | Tomosynthesis, mammo | 448 | 440 | $40K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1,342 | 1,295 | $39K |
| 81003 | 13,677 | 12,242 | $39K | |
| 86140 | 8,774 | 8,355 | $38K | |
| 84132 | 19,010 | 17,358 | $37K | |
| 82948 | 7,607 | 6,005 | $37K | |
| 76604 | 1,450 | 1,441 | $36K | |
| 83970 | 1,126 | 1,099 | $35K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 10,360 | 9,971 | $34K |
| 84100 | 10,640 | 9,416 | $33K | |
| 84295 | 18,619 | 17,092 | $33K | |
| 72170 | 3,430 | 3,392 | $33K | |
| J2704 | Injection, propofol, 10 mg | 2,899 | 2,779 | $32K |
| 84550 | 8,015 | 7,515 | $32K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 10,607 | 9,570 | $32K |
| 85379 | 6,118 | 5,891 | $32K | |
| 93880 | 345 | 331 | $32K | |
| 85730 | 8,117 | 7,807 | $31K | |
| 70491 | 401 | 390 | $31K | |
| 87653 | 1,285 | 1,264 | $31K | |
| 97802 | 408 | 398 | $31K | |
| 76536 | 630 | 624 | $31K | |
| 72050 | 895 | 888 | $31K | |
| 77065 | Tomosynthesis, mammo | 450 | 447 | $30K |
| 72040 | 1,096 | 1,073 | $30K | |
| 82728 | 3,162 | 3,052 | $29K | |
| 0710 | 1,030 | 959 | $29K | |
| 47562 | 182 | 181 | $29K | |
| 87186 | 8,152 | 7,852 | $29K | |
| 82435 | 17,684 | 16,348 | $29K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 3,107 | 1,497 | $29K |
| 84480 | 2,289 | 2,253 | $29K | |
| 86003 | 316 | 294 | $29K | |
| 74019 | 1,751 | 1,723 | $29K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 4,110 | 2,166 | $28K |
| 82550 | 5,218 | 4,655 | $27K | |
| 12001 | 1,641 | 1,598 | $26K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 1,314 | 1,297 | $25K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 2,026 | 1,926 | $25K |
| 73140 | 1,811 | 1,773 | $25K | |
| 82746 | 1,916 | 1,867 | $25K | |
| 83540 | 4,725 | 4,621 | $24K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 401 | 361 | $24K |
| 87340 | 1,807 | 1,778 | $23K | |
| 86592 | 6,651 | 6,568 | $23K | |
| 77336 | 895 | 369 | $22K | |
| 84145 | 1,784 | 1,727 | $22K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 10,420 | 9,995 | $22K |
| J1644 | Injection, heparin sodium, per 1000 units | 3,301 | 1,814 | $22K |
| 82043 | 3,119 | 3,063 | $21K | |
| 0300 | 420 | 367 | $21K | |
| 83520 | 1,821 | 1,781 | $20K | |
| G9793 | Patient is currently on a daily aspirin or other antiplatelet | 2,054 | 1,907 | $20K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 5,176 | 4,960 | $20K |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 1,092 | 1,064 | $19K |
| 73552 | 1,312 | 1,206 | $19K | |
| 85576 | 415 | 384 | $19K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 334 | 317 | $19K |
| 85014 | 18,787 | 17,264 | $18K | |
| 83550 | 3,486 | 3,431 | $18K | |
| 96367 | 1,132 | 1,086 | $18K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 2,584 | 2,165 | $18K |
| 93296 | 639 | 631 | $18K | |
| 70360 | 1,025 | 1,008 | $18K | |
| 85651 | 7,640 | 7,273 | $18K | |
| 77412 | 558 | 52 | $17K | |
| 81002 | 9,458 | 8,851 | $17K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 2,580 | 953 | $17K |
| J1790 | Injection, droperidol, up to 5 mg | 2,111 | 1,935 | $17K |
| 12011 | 843 | 817 | $16K | |
| 86376 | 1,315 | 1,278 | $15K | |
| 12002 | 850 | 822 | $15K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,411 | 1,235 | $15K |
| 73060 | 1,226 | 1,142 | $15K | |
| J1756 | Injection, iron sucrose, 1 mg | 177 | 67 | $15K |
| 86762 | 1,083 | 1,048 | $15K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 6,802 | 6,165 | $14K |
| 97018 | 299 | 91 | $14K | |
| 82010 | 2,987 | 2,812 | $14K | |
| 87070 | 2,467 | 2,377 | $14K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 6,380 | 5,883 | $14K |
| 29125 | 1,121 | 1,053 | $14K | |
| 82140 | 2,143 | 1,988 | $14K | |
| 84153 | 820 | 810 | $14K | |
| 71250 | 158 | 158 | $14K | |
| 87088 | 4,799 | 4,654 | $14K | |
| 86635 | 888 | 846 | $14K | |
| 80069 | 1,556 | 1,520 | $13K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 4,075 | 3,439 | $13K |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 1,204 | 1,137 | $13K |
| P9016 | Red blood cells, leukocytes reduced, each unit | 411 | 366 | $13K |
| 90686 | 2,277 | 2,214 | $13K | |
| 86038 | 1,171 | 1,152 | $12K | |
| 84466 | 1,219 | 1,180 | $12K | |
| 97116 | 1,589 | 844 | $12K | |
| 73221 | 45 | 43 | $11K | |
| 85027 | 1,988 | 1,595 | $11K | |
| 99401 | 862 | 611 | $11K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,882 | 1,717 | $11K |
| 80164 | 872 | 762 | $11K | |
| 93225 | 423 | 416 | $11K | |
| 85018 | 10,880 | 10,006 | $11K | |
| 96376 | 2,582 | 2,383 | $11K | |
| 82248 | 2,609 | 2,464 | $11K | |
| 82274 | 708 | 702 | $10K | |
| 95816 | 330 | 316 | $10K | |
| 96368 | 715 | 706 | $10K | |
| T2041 | Supports brokerage, self-directed, waiver; per 15 minutes | 53 | 24 | $10K |
| 93000 | 443 | 440 | $10K | |
| 80050 | General health panel | 752 | 730 | $10K |
| 71101 | 370 | 366 | $10K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 1,770 | 1,606 | $9K |
| 84403 | 455 | 414 | $9K | |
| 82950 | 1,653 | 1,643 | $9K | |
| 93226 | 236 | 230 | $9K | |
| 82570 | 1,915 | 1,761 | $9K | |
| 99205 | Prolong outpt/office vis | 152 | 147 | $9K |
| Z9725 | 197 | 196 | $8K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,210 | 1,152 | $8K |
| 29515 | 679 | 645 | $8K | |
| 10060 | 465 | 437 | $8K | |
| 87205 | 2,837 | 2,736 | $8K | |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | 484 | 426 | $8K |
| J2060 | Injection, lorazepam, 2 mg | 3,661 | 3,207 | $7K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 99 | 98 | $7K |
| 72070 | 364 | 359 | $7K | |
| J3370 | Injection, vancomycin hcl, 500 mg | 958 | 802 | $7K |
| 87210 | 2,411 | 2,337 | $7K | |
| 95782 | 14 | 14 | $7K | |
| J1953 | Injection, levetiracetam, 10 mg | 807 | 711 | $7K |
| 74178 | 38 | 38 | $7K | |
| 0762 | 988 | 908 | $7K | |
| 93356 | 417 | 404 | $6K | |
| 74022 | 265 | 264 | $6K | |
| 36455 | 334 | 286 | $6K | |
| 87505 | 56 | 55 | $6K | |
| 93925 | 114 | 113 | $6K | |
| 86403 | 583 | 568 | $6K | |
| 90837 | Psychotherapy, 53 minutes with patient | 67 | 51 | $6K |
| 72158 | 13 | 12 | $6K | |
| 93242 | 509 | 507 | $6K | |
| 87807 | 871 | 865 | $6K | |
| 77334 | 52 | 38 | $6K | |
| 77280 | 163 | 130 | $6K | |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | 196 | 124 | $6K |
| J1170 | Injection, hydromorphone, up to 4 mg | 1,126 | 919 | $6K |
| 84436 | 2,993 | 2,938 | $6K | |
| 73560 | 438 | 422 | $5K | |
| 87220 | 1,502 | 1,458 | $5K | |
| 73620 | 209 | 201 | $5K | |
| 3074F | 303 | 301 | $5K | |
| 86431 | 909 | 902 | $5K | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 869 | 835 | $5K |
| 76775 | 166 | 162 | $5K | |
| 78451 | 73 | 72 | $5K | |
| 97597 | 182 | 105 | $5K | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 634 | 489 | $5K |
| 26145 | 45 | 40 | $4K | |
| 93246 | 305 | 305 | $4K | |
| 84146 | 257 | 254 | $4K | |
| 87631 | 128 | 126 | $4K | |
| 87338 | 445 | 438 | $4K | |
| 83001 | 189 | 188 | $4K | |
| 78227 | 18 | 15 | $4K | |
| 76882 | 192 | 190 | $4K | |
| 73120 | 122 | 119 | $4K | |
| 0301 | 442 | 384 | $4K | |
| 85384 | 651 | 600 | $4K | |
| 29530 | 546 | 529 | $4K | |
| 87045 | 602 | 589 | $4K | |
| 90677 | 12 | 12 | $4K | |
| 84479 | 755 | 744 | $4K | |
| 72131 | 61 | 61 | $4K | |
| 90658 | 217 | 217 | $3K | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 197 | 185 | $3K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 79 | 78 | $3K |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | 195 | 186 | $3K |
| 83615 | 720 | 630 | $3K | |
| 99243 | 156 | 155 | $3K | |
| 3077F | 124 | 122 | $3K | |
| 85045 | 904 | 870 | $3K | |
| 92551 | 199 | 199 | $3K | |
| Z6406 | 244 | 173 | $3K | |
| 83516 | 268 | 261 | $3K | |
| 29240 | 749 | 736 | $3K | |
| 36430 | 126 | 120 | $3K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 123 | 13 | $3K |
| 72072 | 120 | 119 | $3K | |
| 29581 | 398 | 74 | $3K | |
| 84481 | 381 | 377 | $3K | |
| 93297 | 125 | 119 | $3K | |
| 93016 | 243 | 243 | $3K | |
| 84155 | 921 | 903 | $3K | |
| 84520 | 530 | 391 | $3K | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 1,165 | 1,035 | $3K |
| 82784 | 314 | 286 | $3K | |
| 77080 | 92 | 92 | $2K | |
| 3079F | 239 | 237 | $2K | |
| 51798 | 149 | 142 | $2K | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 408 | 386 | $2K |
| 82553 | 160 | 112 | $2K | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 388 | 376 | $2K |
| 67042 | 13 | 12 | $2K | |
| 87581 | 129 | 127 | $2K | |
| 73000 | 92 | 90 | $2K | |
| J3105 | Injection, terbutaline sulfate, up to 1 mg | 247 | 214 | $2K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 239 | 228 | $2K |
| 87046 | 570 | 555 | $2K | |
| 87486 | 129 | 127 | $2K | |
| 0510 | 1,572 | 1,505 | $2K | |
| 82565 | 441 | 428 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 384 | 379 | $2K |
| 76000 | 82 | 77 | $2K | |
| 71020 | 338 | 200 | $2K | |
| 29130 | 401 | 386 | $2K | |
| 99223 | Prolong inpt eval add15 m | 49 | 49 | $2K |
| 97535 | Self-care/home management training, each 15 minutes | 213 | 125 | $2K |
| 87899 | 212 | 211 | $2K | |
| 82310 | 385 | 361 | $2K | |
| 86677 | 160 | 159 | $2K | |
| 85390 | 413 | 383 | $2K | |
| 86787 | 154 | 152 | $2K | |
| 84156 | 809 | 747 | $2K | |
| J1630 | Injection, haloperidol, up to 5 mg | 1,321 | 1,167 | $2K |
| 86308 | 327 | 327 | $2K | |
| 97166 | 312 | 309 | $2K | |
| 90791 | Psychiatric diagnostic evaluation | 13 | 13 | $2K |
| 69209 | 246 | 244 | $2K | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 203 | 190 | $2K |
| 86703 | 117 | 116 | $2K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 12 | 12 | $2K |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 187 | 165 | $2K |
| 99218 | 288 | 239 | $1K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 58 | 58 | $1K |
| 84157 | 690 | 650 | $1K | |
| 0324 | 505 | 498 | $1K | |
| J3372 | Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg | 99 | 92 | $1K |
| J3260 | Injection, tobramycin sulfate, up to 80 mg | 81 | 76 | $1K |
| 97016 | 470 | 116 | $1K | |
| 74174 | 12 | 12 | $1K | |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 383 | 382 | $1K |
| 73070 | 124 | 114 | $1K | |
| 82272 | 166 | 162 | $1K | |
| 86800 | 137 | 134 | $1K | |
| 92610 | 29 | 29 | $1K | |
| 51702 | 89 | 82 | $1K | |
| J3360 | Injection, diazepam, up to 5 mg | 97 | 93 | $1K |
| 85347 | 430 | 400 | $1K | |
| 73600 | 46 | 45 | $1K | |
| 82530 | 81 | 80 | $1K | |
| 71100 | 57 | 56 | $1K | |
| 74220 | 59 | 58 | $1K | |
| 90732 | 13 | 13 | $1K | |
| 84402 | 95 | 95 | $1K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 29 | 29 | $1K |
| 82610 | 117 | 113 | $1K | |
| J2560 | Injection, phenobarbital sodium, up to 120 mg | 15 | 13 | $1K |
| 90746 | 13 | 13 | $1K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 23 | 13 | $1K |
| 82810 | 164 | 151 | $1K | |
| 80081 | 12 | 12 | $1K | |
| 0370 | 357 | 351 | $994.76 | |
| 87449 | 104 | 102 | $991.79 | |
| 95819 | 38 | 38 | $981.37 | |
| 76376 | 303 | 300 | $979.85 | |
| 82378 | 122 | 113 | $964.40 | |
| 84460 | 218 | 213 | $914.81 | |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 131 | 107 | $903.14 |
| 49083 | 15 | 12 | $887.32 | |
| 73660 | 91 | 89 | $871.16 | |
| 84134 | 84 | 83 | $870.17 | |
| 93350 | 18 | 16 | $860.09 | |
| 84450 | 206 | 202 | $848.48 | |
| 29105 | 84 | 78 | $834.58 | |
| 86769 | 26 | 25 | $820.13 | |
| 85008 | 997 | 916 | $819.12 | |
| 83002 | 36 | 36 | $791.35 | |
| 64721 | 12 | 12 | $759.00 | |
| 87184 | 227 | 222 | $730.46 | |
| 76999 | 25 | 25 | $704.74 | |
| 86920 | 21 | 12 | $691.53 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 104 | 97 | $689.00 |
| 51701 | 174 | 153 | $684.14 | |
| 80178 | 105 | 95 | $674.69 | |
| 85007 | 885 | 834 | $641.79 | |
| 82785 | 40 | 40 | $615.97 | |
| 90688 | 74 | 74 | $576.38 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 58 | 58 | $536.35 |
| 73521 | 25 | 25 | $534.39 | |
| 82977 | 72 | 72 | $531.92 | |
| 3075F | 28 | 28 | $531.45 | |
| 82105 | 14 | 14 | $520.69 | |
| 70487 | 13 | 12 | $504.28 | |
| 82040 | 148 | 135 | $502.04 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 45 | 45 | $492.12 |
| 72220 | 27 | 27 | $477.82 | |
| 90675 | 24 | 13 | $477.16 | |
| J1940 | Injection, furosemide, up to 20 mg | 128 | 99 | $472.87 |
| 29260 | 281 | 274 | $451.30 | |
| 82945 | 176 | 171 | $446.37 | |
| Z7500 | 13 | 12 | $443.30 | |
| 82731 | 14 | 13 | $440.50 | |
| 80329 | 93 | 84 | $439.86 | |
| 92558 | 15 | 14 | $435.56 | |
| 84075 | 119 | 118 | $435.52 | |
| 84270 | 27 | 27 | $435.22 | |
| 82575 | 52 | 52 | $399.22 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 2,116 | 1,926 | $387.39 |
| 82652 | 40 | 39 | $378.98 | |
| 83037 | 287 | 281 | $375.47 | |
| 86171 | 30 | 30 | $370.24 | |
| A9537 | Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 16 | 14 | $366.94 |
| 82247 | 72 | 51 | $365.44 | |
| 86331 | 30 | 30 | $346.25 | |
| 99232 | Subsequent hospital care, per day, moderate complexity | 19 | 12 | $340.20 |
| Z7610 | 26 | 26 | $321.87 | |
| 73100 | 12 | 12 | $320.99 | |
| Z6404 | 12 | 12 | $289.56 | |
| 81050 | 149 | 148 | $252.26 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 150 | 144 | $241.50 |
| 93321 | 13 | 12 | $233.06 | |
| 83993 | 12 | 12 | $228.44 | |
| 71010 | 88 | 36 | $224.77 | |
| 86200 | 34 | 29 | $219.31 | |
| S0164 | Injection, pantoprazole sodium, 40 mg | 16 | 14 | $194.38 |
| J8540 | Dexamethasone, oral, 0.25 mg | 189 | 165 | $189.86 |
| 86706 | 12 | 12 | $169.20 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 53 | 36 | $167.54 |
| 94760 | 19 | 19 | $138.30 | |
| J0456 | Injection, azithromycin, 500 mg | 44 | 43 | $133.38 |
| 84165 | 25 | 24 | $131.04 | |
| 0305 | 319 | 289 | $129.71 | |
| 3080F | 12 | 12 | $115.48 | |
| J3486 | Injection, ziprasidone mesylate, 10 mg | 16 | 13 | $113.65 |
| 86256 | 13 | 13 | $103.90 | |
| 29540 | 131 | 131 | $97.44 | |
| 0320 | 32 | 31 | $96.67 | |
| 0730 | 12 | 12 | $89.51 | |
| 87075 | 16 | 16 | $88.38 | |
| 82374 | 68 | 67 | $79.33 | |
| 99000 | 143 | 137 | $73.28 | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 33 | 25 | $72.68 |
| 99173 | 152 | 143 | $64.64 | |
| 90651 | 13 | 13 | $61.65 | |
| 83930 | 12 | 12 | $57.92 | |
| J2310 | Injection, naloxone hydrochloride, per 1 mg | 16 | 16 | $54.84 |
| 87077 | 27 | 26 | $53.66 | |
| 86880 | 13 | 13 | $47.87 | |
| 93018 | 14 | 14 | $45.15 | |
| 0636 | 38 | 27 | $39.60 | |
| 86300 | 13 | 12 | $35.76 | |
| G9724 | Patients who had documentation of use of anticoagulant medications overlapping the measurement year | 31 | 29 | $24.04 |
| 36000 | 16 | 12 | $21.80 | |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 47 | 44 | $17.71 |
| S0077 | Injection, clindamycin phosphate, 300 mg | 13 | 13 | $16.12 |
| G8482 | Influenza immunization administered or previously received | 309 | 285 | $14.13 |
| A4657 | Syringe, with or without needle, each | 580 | 69 | $0.03 |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | 80 | 76 | $0.00 |
| 97014 | 92 | 28 | $0.00 | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 18 | 15 | $0.00 |
| G8986 | Carrying, moving & handling objects functional limitation, discharge status, at discharge from therapy or to end reporting | 13 | 13 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 15 | 15 | $0.00 |
| A4649 | Surgical supply; miscellaneous | 206 | 191 | $0.00 |
| G8984 | Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals | 60 | 59 | $0.00 |
| G8985 | Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 142 | 130 | $0.00 |
| 0940 | 40 | 40 | $0.00 | |
| 0370R | 12 | 12 | $0.00 |